A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous (SC) Administered Alirocumab in Healthy Chinese Subjects
Clinical trial NCT02979015 · COMPLETED
Trial details
- NCT number
- NCT02979015
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-29
- Primary completion
- 2017-11-27
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.